Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Monash research program that produced AOD-9604 was specifically asking: can the lipolytic activity of growth hormone be uncoupled from its growth-promoting and metabolic side effects
Unlike full-length HGH, AOD-9604 does not significantly impact blood sugar levels or cause IGF-1 elevation, making it a safer alternative for fat loss
Factors that influence this include: Baseline B12 levels Symptoms and severity Absorption issues or medical conditions Diet and lifestyle factors Some people maintain healthy levels with occasional injections, while others require more consistent support
The oral formulation was associated with mild GI symptoms (nausea, loose stools) at rates similar to placebo
US$ 26.08
US$ 25.90
US$ 29.13
